Skin Cancer Evaluation. Simplified.

An objective, non-invasive skin cancer evaluation platform, accessible at the point of care via a handheld, point-and-click device.

Learn More

DermaSensor uses light to non-invasively scan skin lesions to detect properties consistent with malignancy at a cellular and subcellular level. It’s like an ultrasound, but using light instead of sound. The intuitive handheld device provides an immediate, objective result.

How It Works

Scan only those lesions where the next step is unclear.


Identify equivocal lesions where an objective risk assessment would be helpful.


Use our device to analyse, and receive an "Investigate Further" or "Monitor" result.


Counsel your patient on next steps using the objective result to assist in your decision making.

Device Application


  • Simple design, effortless application
  • Non-invasive optical spectroscopy
  • Beneath the skin, cellular-level analysis
  • AI-Powered, ultra-minitiarized ESS Technology
  • 97% sensitivity across common skin cancers1
  • 68% decrease in missed skin cancers with use of the device2

DermaSensor’s technology holds the promise of improving early detection of skin cancer by equipping primary care providers with a tool to better assess it.

David Leffell, M.D.

Chief, Section of Dermatologic Surgery and Cutaneous Oncology, Yale School of Medicine Scientific Advisory Board, DermaSensor

david lafell
David Leffell

With improved confidence in conducting skin cancer checks, you have the potential to significantly increase detection rates. Speak to one of DermaSensor's consultants today to arrange a 30 day trial of the DermaSensor device in your practice.

Contact Us

DermaSensor looks beyond the visual to improve your decision-making and confidence.

According to the results of a study with 57 GPs, skin cancer detection increases by 13% (from 81% to 94% sensitivity) when using DermaSensor, with no significant decrease in specificity.2

Book a Demo


1Manolakos D et al. Clinical Validation of a Handheld Elastic Scattering Spectroscopy Artificial Intelligence Device, Presentation at American Academy of Dermatologists Innovation Academy, July 20-24, 2022.

2Thames T et al. Clinical Utility of a Handheld Elastic Scattering Spectroscopy Tool and Machine Learning on the Diagnosis and Management of Skin Cancer. Poster Presentation, STFM Annual Spring Conference, April 30-May 4, 2022.

80-0006.1 v2

Scroll to Top